# Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)

> **NCT00387036** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Fluticasone
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00387036
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Termininated for business reasons
- **Last updated:** 2016-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387036, "Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00387036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*